SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Spherix Incorporated on April 2, 2014. The report discloses events occurring on April 2, 2014, and references a patent assignment transaction dated December 31, 2013. The registrant is incorporated in Delaware with principal executive offices in Bethesda, Maryland.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of non-financial events and the release of an investor presentation rather than a financial statement.
Material Changes and Events
- Investor Presentation: On April 2, 2014, the Company made a new investor presentation available (Exhibit 99.1).
- Patent Assignments: A list of patents and patent applications assigned by Rockstar Consortium US LP to the Company on December 31, 2013, is included as Exhibit 99.2.
Guidance, Outlook, and Risks
The filing explicitly states that the information provided, including the attached investor presentation, is furnished pursuant to Item 7.01 (Regulation FD) and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement under the Securities Act of 1933, except as expressly set forth. No specific guidance, outlook, or risk factors are detailed within the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation) for detailed financial projections and strategic outlook.
- Examine Exhibit 99.2 to verify the specific patents and applications assigned from Rockstar Consortium US LP.
- Confirm the legal status of the patent assignments and any associated financial terms not detailed in this summary.
- Verify if the investor presentation contains forward-looking statements that require separate risk assessment.